About Injectsense
Injectsense is a Healthcare company based in Emeryville (United States) founded in 2014. It operates as a sensor-coupled platform is utilized for disease tracking and therapy management. It operates in the Healthcare and Technology sectors. Injectsense has raised $16.43 million across 5 funding rounds from investors including HHS and National Eye Institute. The company has 15 employees. Injectsense offers products and services including Intraocular Pressure Sensor. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Remote Monitoring. Its legal entity is INJECTSENSE, INC. Its competitors include Tyto Care, Edwards Lifesciences, BioIntelliSense, Endotronix and CoachCare and 5 more; 9 of its 10 listed competitors have raised funding.
Company details
Injectsense was founded in 2014 in Emeryville, United States, and operates within the digital health sector. A self-anchoring smart sensor platform is provided to interface with biological media such as blood or tissue, capturing data on physiological functions without electronic disruption. This system enables physicians to establish patient baselines for ongoing monitoring and comparison in disease management.
- Headquarters Emeryville, United States
- Employees 15
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website injectsense.com
- Social LinkedIn Instagram
- Legal Name Injectsense, Inc
- Total Equity Funding$16.43M (USD)
in 5 rounds
- Latest Funding Round$2.5M (USD), Series A
Nov 2023
- InvestorsHHS
& 1 more
- Employee Count15
Products & Services of Injectsense
Injectsense offers a comprehensive portfolio of products and services, including Intraocular Pressure Sensor.
Monitors eye pressure continuously for glaucoma treatment support.
Funding Insights of Injectsense
Injectsense has successfully raised a total of $16.43M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $2.5 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $16.43M
- Total Rounds 5
- Last Round Series A — $2.5M
- First Round $9.84M
(Oct 2017)
- Investors Count 2
All 5 funding rounds of Injectsense with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2023 | $2.5M | Series A | – | – | – |
| Mar 2022 | $1.7M | Grant | – | – | |
| Feb 2022 | $1.62M | Grant | – | – | |
| Apr 2019 | $4.09M | Series A | – | – | – |
| Oct 2017 | $9.84M | Series A | – | – | – |
2 investors in total: 2 institutional.
Investors in Injectsense
Injectsense has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and National Eye Institute.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Vision research is conducted to eliminate vision loss. | – | nei.nih.gov | Bethesda, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Injectsense
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Injectsense
18 people are tracked at Injectsense (6 in leadership, 11 in board & advisors, 1 in team); the tracked headcount is 15.
| Name | Role | Group |
|---|---|---|
Tom Breunig | Director of Corporate Communications | Leadership |
Kevin Berg | COO At Injectsense, Co-founder Of Injectpower | Leadership |
Sebnem Eler Acar | Director, Medical Product Management & Digital Health | Leadership |
Ariel Cao | President, CEO & Co-Founder | Leadership |
Enrique Malaret | COO & Co-Founder | Leadership |
David Huber | Senior Director Applied Research | Leadership |
Myron Yanoff | Medical Advisor | Board & advisors |
Ernesto Collazo | Medical Advisor | Board & advisors |
William Daney | Medical Advisor | Board & advisors |
Jason Bacharach | Medical Advisor | Board & advisors |
Bernhard Boser | Technology Advisor | Board & advisors |
James L. Mcgregor | Business Advisor | Board & advisors |
Arthur Sit | Medical Advisor | Board & advisors |
Kuldev Singh | Medical Advisor | Board & advisors |
Stephen Sinclair | Medical Advisor | Board & advisors |
Richard Lindstrom | Medical Advisor | Board & advisors |
Iqbal Ahmed | Medical Advisor | Board & advisors |
Andrew Amiel | Investor, EVP Business Development and Investor Relations | Team |
Complete people profiles for Injectsense
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Injectsense
3 dated milestones of Injectsense across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Injectsense is founded.
- Funding First funding round of $9.8M.
- Funding Latest funding round, Series A, of $2.5M.
Competitors of Injectsense
Injectsense has 10 listed competitors in our database, 9 of them funded. They include Tyto Care, Edwards Lifesciences, BioIntelliSense, Endotronix and CoachCare, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| tytocare.com | 2011 | Netanya, Israel | $199.5M | – | Medical consultations are facilitated via self-exams and remote diagnostic devices. | |
| edwards.com | 1958 | Irvine, United States | – | 19,800 | Medical devices for structural heart disease are developed and provided. | |
| biointellisense.com | 2018 | Redwood, United States | $82M | 26 | Vital signs are monitored via a single-use patch and platform. | |
| endotronix.com | 2007 | East Peoria, United States | $154.77M | 104 | Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | |
| coachcare.com | 2013 | New York, United States | $60.2M | – | Remote monitoring platform for tracking patient activity | |
| lumen.me | 2014 | Ramat Hasharon, Israel | $77.5M | 1 | Breath-based metabolism tracker for personalized diet plans is provided. | |
| cardionet.com | 1999 | Conshohocken, United States | $141.9M | – | Outpatient cardiac arrhythmia monitoring solutions are provided by CardioNet. | |
| picooc.com | 2013 | Beijing, China | $46M | – | Smart body composition scales and sphygmomanometers are provided by PICOOC. | |
| somatix.com | 2015 | New York, United States | $21.24M | – | AI-based remote health monitoring tools are provided for patient care. | |
| openwater.health | 2016 | San Francisco, United States | $54M | – | Provider of imaging technologies for medical diagnosis and treatments |
Detailed competitors of Injectsense
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
10 companies that operate in the same segment as Injectsense (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts | 2016 | Bengaluru, Karnataka, India | USD 716.99 M | – | 1,832 | |
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | – | – | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | – | 1,746 | |
Tech-enabled mental health solutions for employers are provided. | 2016 | New York, New York, United States | USD 473.73 M | – | 3,902 | |
App-based health insurance is offered to individuals and businesses. | 2016 | Paris, Ile de France, France | USD 863.12 M | – | 1,606 | |
Virtual care programs for managing chronic diseases are provided. | 2011 | San Francisco, California, United States | USD 450.12 M | USD 260.21 M | 992 | |
AI-driven EMR and practice management software is delivered for clinics. | 2010 | Boca Raton, Florida, United States | USD 329.17 M | – | 2,470 | |
Cloud-based administrative tools for healthcare providers are offered. | 1997 | Watertown, United States | USD 40 M | – | – | |
Membership-based primary care platform is offered for employees and consumers. | 2007 | San Francisco, California, United States | USD 402.56 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Injectsense
Complete news archive for Injectsense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Injectsense
Injectsense was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Injectsense is headquartered in Emeryville, United States. It is registered at Emeryville, California, United States.
Injectsense is a funded company, having raised a total of $16.43M across 5 funding rounds to date. The company's 1st funding round was a Series A of $9.84M, raised on Oct 2017.
Injectsense has 15 employees.
Injectsense was founded in 2014 in Emeryville, United States, and operates within the digital health sector. A self-anchoring smart sensor platform is provided to interface with biological media such as blood or tissue, capturing data on physiological functions without electronic disruption. This system enables physicians to establish patient baselines for ongoing monitoring and comparison in disease management.
Injectsense's top competitors include Tyto Care, Endotronix and BioIntelliSense.
Injectsense offers Intraocular Pressure Sensor.
Injectsense has 2 investors. Key investors include HHS, and National Eye Institute.
Injectsense operates through Injectsense, Inc.